The Amazon, Berkshire Hathaway, and JPMorgan Chase announcement shows that new action is possible.

As large companies join forces to tackle healthcare, they will accelerate innovation and disruption in the broader industry.

In a turbulent environment, it is vital for healthcare companies to build business models that can withstand uncertainty and change.

As the healthcare landscape evolves, stakeholders in the pharmacy value chain need to rethink how they organize to deliver value.

To capitalize on the rapid growth in membership, insurers need to rethink the way they design and administer MA plans.

Fraudulent products are booming in the global economy. And although we hear a lot about fake handbags, watches, and other luxury goods, counterfeit drugs are far more common.

In his new book, Mistreated, former Permanente Medical Group CEO Robert Pearl diagnoses the woes afflicting one of the country’s largest industries.

We must discard several misconceptions and reimagine how our society confronts this deadly, and expensive, disease.

Recent ADA-related challenges raise questions over corporate initiatives designed to improve employees’ health.

Robert Henkel, president and CEO of Ascension Health, the delivery subsidiary of Ascension, has helped lead the transformation of the nation’s largest Catholic healthcare system as it fulfills its mission in a changing healthcare environment.

Four strategies for creating value in life sciences.

A comprehensive model shows how far-reaching trends in the massive industry will influence the growth of profit pools — and how payors and providers should respond.